Go to Contents Go to Navigation

PM orders full review of EMA's findings before resuming use of AstraZeneca's vaccine

All News 11:07 April 08, 2021

SEOUL, April 8 (Yonhap) -- Prime Minister Chung Sye-kyun on Thursday ordered health authorities to thoroughly and swiftly review the latest findings by the European Medicines Agency (EMA) on the safety of AstraZeneca's vaccine.

The Korea Disease Control and Prevention Agency should "swiftly reach a scientific conclusion on the findings and share the results with the public in a transparent manner," he said.

While rare blood clots have been reported among people administered with the vaccine, the EMA said "the benefits (of administering the vaccine) outweigh the risks," he added.

Prime Minister Chung Sye-kyun speaks during a daily interagency meeting on the new coronavirus response at the government complex in Seoul on April 8, 2021. (Yonhap)

On Wednesday, the country suspended the use of AstraZeneca's vaccine for people under age 60, special education instructors and school nurses to "prioritize people's health and safety." Later that day, the EMA announced there is a "possible link" between the vaccine and unusual blood clot cases.

The government will decide on resuming use of AstraZeneca's vaccine for the group after closely analyzing the EMA's findings, Chung said.

"We will focus on devising effective antivirus measures as the country is at risk of entering a fourth wave of infections," he said.

This March 23, 2021, photo shows the coronavirus vaccine product made by British-Swedish pharmaceutical giant AstraZeneca. (Yonhap)


Send Feedback
How can we improve?
Thanks for your feedback!